World's Best Scientists 2026 revealed!
Stephen Salloway

Stephen Salloway

D-Index & Metrics

Medicine

D-Index
97
Citations
63321
World Ranking
9065
National Ranking
4676

Overview

Stephen Salloway is a researcher affiliated with Brown University in the United States. Their scholarly work primarily focuses on Medicine, with significant contributions in Psychiatry and Mental Health, Physiology, Cognitive Neuroscience, Neurology, and Radiology, Nuclear Medicine and Imaging. The main topics covered by their research include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, Advanced Neuroimaging Techniques and Applications, Cholinesterase and Neurodegenerative Diseases, Frailty in Older Adults, and Health Systems, Economic Evaluations, and Quality of Life.

They have published extensively in prominent academic venues. Notably frequent publication venues include:

  • Alzheimer s & Dementia
  • The Journal of Prevention of Alzheimer s Disease
  • Neurology
  • JAMA Neurology
  • Journal of the International Neuropsychological Society

Among recent papers, key publications authored or co-authored by Stephen Salloway include:

  • "Donanemab in Early Symptomatic Alzheimer Disease," 2023, JAMA
  • "Donanemab in Early Alzheimer's Disease," 2021, New England Journal of Medicine
  • "Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group," 2021, The Lancet Neurology
  • "A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease," 2020, Nature Medicine
  • "Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease," 2021, JAMA Neurology

Stephen Salloway collaborates regularly with a number of researchers. Frequent co-authors include:

  • Randall J. Bateman
  • Tammie L.S. Benzinger
  • Jasmeer P. Chhatwal
  • Johannes Levin
  • Brian A. Gordon

Best Publications

  • Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

    Bruno Dubois;Howard H. Feldman;Claudia Jacova;Steven T. DeKosky

  • Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease

    Randall J. Bateman;Chengjie Xiong;Tammie L.S. Benzinger;Anne M. Fagan

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel

  • The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

    Jeff Sevigny;Ping Chiao;Thierry Bussière;Paul H Weinreb

  • Revising the definition of Alzheimer's disease: a new lexicon.

    Bruno Dubois;Howard H. Feldman;Howard H. Feldman;Howard H. Feldman;Claudia Jacova;Jeffrey L. Cummings

  • Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

    Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow

  • Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

    Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens

  • Donanemab in Early Alzheimer's Disease.

    Mark A Mintun;Albert C Lo;Cynthia Duggan Evans;Alette M Wessels

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression

    Donald A. Malone;Darin D. Dougherty;Ali R. Rezai;Linda L. Carpenter

  • Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.

    Bruno Dubois;Nicolas Villain;Giovanni B. Frisoni;Gil D. Rabinovici

  • Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

    B D Greenberg;Lutgardis Gabriëls;D A Malone;A R Rezai

  • Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

    Oliver Preische;Oliver Preische;Stephanie A. Schultz;Anja Apel;Anja Apel;Jens Kuhle

  • A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

    S. Salloway;R. Sperling;S. Gilman;N.C.I. Fox

  • Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder

    Benjamin D Greenberg;Donald A Malone;Gerhard M Friehs;Ali R Rezai

  • Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

    Randall J Bateman;Paul S Aisen;Bart De Strooper;Bart De Strooper;Nick C Fox

  • Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study

    Brian A Gordon;Tyler M Blazey;Yi Su;Amrita Hari-Raj

  • Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis

    Davis C. Ryman;Natalia Acosta-Baena;Paul S. Aisen;Thomas Bird

  • Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

    Reisa Sperling;Stephen Salloway;David J Brooks;Donatella Tampieri

  • Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

    R.J. Bateman;P.S. Aisen;B. De Strooper;N.C. Fox

Frequent Co-Authors

Peter R. Schofield
Peter R. Schofield Neuroscience Research Australia
Randall J. Bateman
Randall J. Bateman Washington University in St. Louis
John C. Morris
John C. Morris Washington University in St. Louis
Reisa A. Sperling
Reisa A. Sperling Brigham and Women's Hospital
Tammie L.S. Benzinger
Tammie L.S. Benzinger Washington University in St. Louis
Alison Goate
Alison Goate Icahn School of Medicine at Mount Sinai
Nick C. Fox
Nick C. Fox University College London
Jasmeer P. Chhatwal
Jasmeer P. Chhatwal Harvard University
Anne M. Fagan
Anne M. Fagan Washington University in St. Louis
Clifford R. Jack
Clifford R. Jack Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of healthcare careers, many of which can be started or advanced through flexible online degrees. One popular entry-level field is medical billing and coding, with many accredited medical billing and coding schools with financial aid available for those seeking affordable study options.

If you’re interested in nursing, you may wonder, do you have to take the teas test to get into nursing school? Many programs now offer alternative admission routes, easing the path for aspiring nurses.

For those already in the healthcare field, management roles are accessible through healthcare administration degree programs online, allowing you to level up your career while balancing work and study.

Registered nurses can advance their clinical expertise through adn to fnp programs, enabling a seamless transition from associate degree to family nurse practitioner. These pathways provide flexibility and support, allowing you to shape your healthcare career on your terms.

Best Scientists Citing Stephen Salloway

Trending Scientists